BRCA1 and ovarian cancer: In contrast, our studies in multiple ovarian cancer cell lines found that E2F1 represses BRCA1 expression, and that this repression requires the DNA methyltransferase DNMT1 and is correlated with CpG hypermethylation of the BRCA1 promoter.